WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles

New stock news | Zhejiang Jing pharmaceutical (688266.SH) submits listing application to Hong Kong Stock Exchange.

New Stock News | Global Horticulture Delivers Prospectus to Hong Kong Stock Exchange

New stock news: Huada Beidou submits listing application to Hong Kong Stock Exchange.
New stock news | Zhejiang Jing pharmaceutical (688266.SH) submits listing application to Hong Kong Stock Exchange.

New Stock News | Global Horticulture Delivers Prospectus to Hong Kong Stock Exchange

New stock news: Huada Beidou submits listing application to Hong Kong Stock Exchange.






